January | View Newsletter

February | View Newsletter

March | View Newsletter

Includes:

• PROVENGE® PROTOCOL AMENDMENT

• Xinlay™ Access Program Cancelled

• Bone-Targeted Prostate Cancer Therapy

• Us TOO International 4-Star Rating

• New Us TOO Educational Brochure

• Read more..

Includes:

• Genome Project Targets Cancer

• The Unseen Patient

• Big Grant to Predict Cancer Outcomes

• Procyon’s PSP94 Marker is Better

• Special Events Feature “Dr. Ruth”

• 2005 Us TOO HotSheet Article Index

• Read more..

 Includes:

• From the Doctor: Physician Commentary on Selected Articles in This Month’s HotSheet

• Medicare CAP Update

• Alternative Therapies Are Commonly Used by Prostate Cancer Patients

• Life Begins Again at 51

• Daily Herald Employees Contribute to Us TOO

• Read more..

April | View Newsletter

May | View Newsletter

June | View Newsletter

Includes:

• From the Doctor: Physician Commentary on Selected Articles in This Month’s HotSheet

• Delayed Intervention May Combat Over treatment of Prostate Cancer

• Online Auction to Benefit Founder’s Fund

• A New Molecular Test—Prostate Px™

• Win the Fight—By Col. Bob Lindsey

• Read more..

Includes:

• From the Doctor: Physician Commentary on
  Selected Articles in This Month’s HotSheet

• Highlights from the 2006 ASCO/ASTRO
  Prostate Cancer Symposium

• Online Auction to Benefit Founder’s Fund

• Life Insurance Offered to Cancer Survivors

• Study Looking for Participants

• Why Bone Is Such an Attractive Target

• Read more..

Includes:

• From the Doctor: Physician Commentary on
  Selected Articles in this month’s HotSheet

• Senators Advocate Continued PAP Assistance
  for Medicare Beneficiaries

• Still Rolling: GVAX Immunotherapy

• Study Finds Gene Associated with
  Prostate Cancer

• Living with Urinary Incontinence

• Read more..

July | View Newsletter

August | View Newsletter

September | View Newsletter

Includes:

• Us TOO Seeks Board Member
  Applications

• HR 863 Recommends Increased Federal
  Support for Innovative Imaging

• New Partners Guide Now Available

• Highlights of the 2006 ASCO Meeting

• Cesamet™ Receives FDA Approval

• Doctor Mark Moyad’s New Column -
  The Magic Pill For Weight Loss: Part I

• Read more..

Includes:

• From the Doctor: Physician Commentary on
  Selected Articles in This Month’s HotSheet

• New NCI Clinical Trial—Targeted Therapy
  for Metastatic Prostate Cancer

• US Rep. Fossella Leads Sponsorship of Men’s
  Health Act of 2006

• Cryotherapy for Recurrent Prostate Cancer

• Companies Show Their Support for Us TOO

• Sipuleucel-T in Hormone Refractory Cancer

• Read more..

Includes:

• A Proud Partner of Us TOO Takes a Shot at
  Prostate Cancer

• Prostate Cancer Awareness Month
  Patient Events
• From the Doctor: Physician Commentary on
  Selected Articles in This Month’s HotSheet
• Cryotherapy for Recurrent Prostate Cancer…
  A Patient’s Story
• Read more..
  

October | View Newsletter

November | View Newsletter

December | View Newsletter

Includes:

• Special Burning Issues Supplement: Clinical Trials for Advanced Prostate Cancer and link to appropriate PDF

• Us TOO’s Sneakers@Work Day

• Us TOO Participates in Federal Campaign

• Lower PSA Threshold for Black Men

• Us TOO Compliant with National Health Council Standards of Excellence

• Us TOO at Rudi Giuliani, Cytogen NASDAQ Opening Bell Ceremony

• Read more..

Includes:

• Special Burning Issues Supplement: Us TOO Celebrates Prostate Cancer Awareness Activities

• Us TOO Publishes 2005 Annual Report

• Focal Cryoablation Effective in Destroying
  Prostate Cancer

• Good Long-Term Results with Hi-Dose IMRT

• Circles of Love Goes To School

• Bone Loss Related to Hormone Therapy —
  What To Do? (RTOG 0518)

• NCI Clinical Trials at the NCI Clinical Center

• Read more..

Includes:

• Imagine

• Prostate Cancer and Intimacy

• Transcript of October 5th Teleconference

• From the Doctor: Physician Commentary on
  Selected Articles in This Month’s HotSheet

• End of Life Webcast Transcript Available

• Genetic Susceptibility for Prostate Cancer

• International Conference on Prostate Cancer

• AstraZeneca’s Patient Assistance Program
  (PAP) Expands Eligibility

• Read more..